首页> 美国卫生研究院文献>British Journal of Cancer >Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine

【2h】

Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine

机译：CA 19-9水平在吉西他滨治疗无法手术的胰腺腺癌患者中的预后价值

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 British Journal of Cancer
作者
C Ziske; C Schlie; M Gorschlüter; A Glasmacher; U Mey; J Strehl; T Sauerbruch; I G H Schmidt-Wolf;
展开▼
作者单位

展开▼
年(卷),期 2003(89),8
年度 2003
页码 1413–1417
总页数 5
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Ca19-9 pancreatic cancer gemcitabine;

机译：Ca19-9;胰腺癌;吉西他滨;

相似文献

外文文献
中文文献
专利

1. Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine [J] . C Ziske, C Schlie, M Gorschlüter, British Journal of Cancer . 2003,第8期

机译：CA 19-9水平在吉西他滨治疗不能手术的胰腺腺癌患者中的预后价值
2. Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine. [J] . Saad ED, Machado MC, Wajsbrot D, International journal of gastrointestinal cancer . 2002,第1期

机译：吉西他滨治疗晚期胰腺癌患者的治疗前CA 19-9水平可作为预后因素。
3. Preoperative CA 19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with surgical resection and adjuvant concurrent chemoradiotherapy. [J] . Hallemeier CL, Botros M, Corsini MM, American Journal of Clinical Oncology: Cancer Clinical Trials . 2011,第6期

机译：术前CA 19-9水平是胰腺腺癌患者的重要预后因素，采用手术切除和辅助同时放化疗进行治疗。
4. Prognostic importance of pleural attachment status measured by pretreatment CT images in patients with stage IA lung adenocarcinoma: Measurement of the ratio of the interface between nodule and neighboring pleura to nodule surface area [C] . Y. Kawata, N. Niki, M.Kusumoto, SPIE Medical Imaging Conference . 2018

机译：IA期肺腺癌患者通过CT预处理图像测量胸膜附着状态的预后重要性：结节与邻近胸膜之间的界面与结节表面积之比的测量
5. Does pancreaticoduodenectomy with venous resection increase median survival when compared to palliative therapy in patients with borderline resectable pancreatic adenocarcinoma of the head of the pancreas? [D] . Lennon, Erin Frances 2010

机译：与颅底可重型胰腺腺癌患者的痛苦治疗相比，胰腺切除术治疗中位生存率是否增加了胰腺的头部胰腺炎的患者？
6. Prognostic Significance of Carbohydrate Antigen 19-9 in Unresectable Locally Advanced Pancreatic Cancer Treated With Dose-Escalated Intensity Modulated Radiation Therapy and Concurrent Full-Dose Gemcitabine: Analysis of a Prospective Phase 1/2 Dose Escalation Study [O] . Jeffrey M. Vainshtein, Matthew Schipper, Mark M. Zalupski, -1

机译：前瞻性1/2期剂量递增研究分析：糖类抗原19-9不能切除的局部晚期胰腺癌的治疗随剂量逐步升高调强放射治疗和并发全剂量化疗的预后意义
7. Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine [O] . Ziske, C, Schlie, C, Gorschlüter, M, 2003

机译：CA 19-9水平在吉西他滨治疗无法手术的胰腺腺癌患者中的预后价值

Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine

著录项

引文网络

相似文献

相关主题

期刊订阅